Precision Biosciences (DTIL) Short-term Investments (2024 - 2026)

Precision Biosciences (DTIL) has reported Short-term Investments for 3 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $4.8 million, up 1053.03% from the prior year.
• Short-term Investments slipped to $1.8 million in Q1 2026 per DTIL's latest filing, from $4.8 million in the prior quarter.
• Across five years, Short-term Investments topped out at $4.8 million in Q4 2025 and bottomed at $413000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $2.4 million across 3 years, with a median of $2.1 million in 2024.
• On a YoY basis, Short-term Investments climbed as much as 1053.03% in 2025 and fell as far as 1053.03% in 2025.
• Precision Biosciences' Short-term Investments stood at $413000.0 in 2024, then jumped by 1053.03% to $4.8 million in 2025, then tumbled by 61.91% to $1.8 million in 2026.
• Business Quant data shows DTIL's Short-term Investments at $1.8 million in Q1 2026, $4.8 million in Q4 2025, and $413000.0 in Q4 2024.